For: | Antwi-Amoabeng D, Beutler BD, Moody AE, Kanji Z, Gullapalli N, Rowan CJ. Management of hypertension in COVID-19. World J Cardiol 2020; 12(5): 228-230 [PMID: 32547717 DOI: 10.4330/wjc.v12.i5.228] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v12/i5/228.htm |
Number | Citing Articles |
1 |
Leila Moftakhar, Elahe Piraee, Mohammad Mohammadi Abnavi, Parisa Moftakhar, Habibollah Azarbakhsh, Aliasghar Valipour, Massimo Salvetti. Epidemiological Features and Predictors of Mortality in Patients with COVID-19 with and without Underlying Hypertension. International Journal of Hypertension 2021; 2021: 1 doi: 10.1155/2021/7427500
|
2 |
Haojun Yang, Yunfang Chi, Zhuohui Chen, Yishu Fan, Haiyue Wu, Xinhang Hu, Tong Wu, Bo Xiao, Mengqi Zhang. Differential Diagnosis and Hospital Emergency Management for Fastlane Treatment of Central Nervous System Infection Under the COVID-19 Epidemic in Changsha, China. Frontiers in Neurology 2020; 11 doi: 10.3389/fneur.2020.555202
|
3 |
Zhen-Mu Jin, Ji-Chan Shi, Mo Zheng, Que-Lu Chen, Yue-Ying Zhou, Fang Cheng, Jing Cai, Xian-Gao Jiang. Increased levels of lactate dehydrogenase and hypertension are associated with severe illness of COVID-19. World Journal of Clinical Cases 2022; 10(1): 128-135 doi: 10.12998/wjcc.v10.i1.128
|
4 |
Li Che, Guangshu Chen, Xingdong Cai, Zhefan Xie, Tingting Xia, Wei Zhang, Shengming Liu, Si Qin. Bioinformatics Approach Predicts Candidate Targets for SARS‐CoV‐2 Infections to COPD Patients. BioMed Research International 2022; 2022(1) doi: 10.1155/2022/1806427
|
5 |
Shilpa Bhuaptrai Shah. COVID-19 and Progesterone: Part 1. SARS-CoV-2, Progesterone and its potential clinical use. Endocrine and Metabolic Science 2021; 5: 100109 doi: 10.1016/j.endmts.2021.100109
|
6 |
Jonas K. Kurzhals, Gina Klee, Hauke Busch, Victoria Hagelstein, Detlef Zillikens, Patrick Terheyden, Ewan A. Langan, Rashidul Alam Mahumud. The impact of the Covid-19 pandemic on quality of life in skin cancer patients. PLOS ONE 2021; 16(8): e0255501 doi: 10.1371/journal.pone.0255501
|